Platelet Activation Induced by Antiprothrombin Antibodies May Explain Anti-FXa Therapy Failure in Patients With Antiphospholipid Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thrombosis and Haemostasis (JTH)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Antiprothrombin Antibodies Induce Platelet Activation: A Possible Explanation for Anti-FXa Therapy Failure in Patients With Antiphospholipid Syndrome?
J. Thromb. Haemost. 2021 Mar 28;[EPub Ahead of Print], W Chayoua, PLR Nicolson, JCM Meijers, C Kardeby, L Garcia-Quintanilla, KMJ Devreese, B de Laat, SP Watson, PG de GrootFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.